STOCK TITAN

INNOVAQOR INC - $INQR STOCK NEWS

Welcome to our dedicated page for INNOVAQOR news (Ticker: $INQR), a resource for investors and traders seeking the latest updates and insights on INNOVAQOR stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect INNOVAQOR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of INNOVAQOR's position in the market.

Rhea-AI Summary
InnovaQor, Inc. (INQR) announces a significant reduction in common shares through an exchange for Series E and F Preferred Stock, reducing the total from 244,953,286 to 204,253,286. The exchange value is set at $0.005 per common share, with each shareholder receiving 50% in Series E and 50% in Series F Preferred Stock. The stated value of each preferred stock increases annually, providing a restructuring mechanism that aims to appeal to investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
none
-
Rhea-AI Summary
InnovaQor, Inc. (OTC: INQR) CEO Darrell Peterson's Year-End Message to Shareholders
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
none
-
Rhea-AI Summary
InnovaQor, Inc. (OTC: INQR) CEO Darrell Peterson provided an update on the development of Curallo, a next-generation platform for medical professionals, and discussed the contemplated share exchange offer to reduce the number of common shares outstanding. The company also confirmed renewed sales and marketing efforts to add more revenue from existing products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
InnovaQor, Inc. (INQR) authorizes two new series of preferred stock, Series E and Series F, for potential exchange offer to common shareholders. The Series E Mandatory Convertible Preferred Stock has a mandatory conversion date of December 31, 2026, and the Series F Mandatory Convertible Preferred Stock has a mandatory conversion date of December 31, 2027. The stated value of each series of preferred stock initially is $100, increasing by $20 upon each anniversary of issuance. The exchange offer is being considered as an alternative to completing a reverse split of common stock to attract new investors. The terms and timing of the exchange offer are subject to final approval by the Board of Directors and market conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
InnovaQor CEO confirms development of new product Curallo, a healthcare communication platform. Company aims for increased revenues from EHR product and IT services. Curallo website launched for user input and updates. Ambition to list on stock exchange.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.03%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.53%
Tags
none
INNOVAQOR INC

OTC:INQR

INQR Rankings

INQR Stock Data

367.43k
207.52M
11.98%
Computer Systems Design Services
Professional, Scientific, and Technical Services
Link
United States of America
West Palm Beach